LICENSES AND AGREEMENTS (Details Textual) - USD ($) $ in Thousands, shares in Millions		1 Months Ended	12 Months Ended
	Sep. 14, 2016	Nov. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Research and Development Expense, Total			$ 28,037	$ 15,470	$ 3,849
KarolinskaUniversityHospital [Member]
Research and Development Expense, Total			100
Payments For Clinical Trials Agreement			1,600
Repayments To Be Made For Termination Of Licence Agreement	$ 2,200
Payments To Be Made For Other Related Agreements	2,600
National Cancer Institute [Member]
Research and Development Expense, Total			500
Exclusive Patent License Agreement [Member]
Research and Development Expense, Total			400	400
Payments For Upfront Licensing Fee			800
Moffitt License Agreement [Member]
Research and Development Expense, Total			700	700	400
Payments For Upfront Licensing Fee			$ 100
Agreement Term			20 years
Cooperative Research and Development Agreement [Member]
Research and Development Expense, Total			$ 1,800	2,000	$ 1,000
Agreement Term			5 years
PolyBioCept, AB - Exclusive and Co-Exclusive License Agreement [Member]
Research and Development Expense, Total			$ 2,700
Payments For Upfront Licensing Fee			2,500
Payment For Upfront Exclusive License	2,500
Additional Milesone Payable	$ 8,700
Number Of Unregistered Common Stock To Be Issued	2,219,376
ReimbursementIn Relation To Transfer Of Knowhow	$ 200
Clinical Trials Management Fees Payable	100
Consulting Fees Receivable	$ 200
Initial Term Of Licence Agreement	30 years
WuXi Apptech, Inc - Manufacturing and Services Agreement [Member]
Research and Development Expense, Total			$ 2,400	$ 0
Agreement Term		3 years
WuXi Apptech, Inc - Manufacturing and Services Agreement [Member] | Manufacturing Suites [Member]
Manufacturing and Services Agreement, Amount Payable		$ 2,500
WuXi Apptech, Inc - Manufacturing and Services Agreement [Member] | Commercial Manufacturing cGMP Suite [Member]
Manufacturing and Services Agreement, Amount Payable		$ 5,850